Preview Mode Links will not work in preview mode

ACR Journals On Air

Dec 27, 2022

In this episode, we welcome the lead author of Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Dr. Eric Morand of Monash University. The objective of this multicenter clinical trial in lupus (recently published in “

Dec 13, 2022

Join us this week as we interview the lead author of “Genicular Nerve Block for Pain Management in Patients with Knee Osteoarthritis: A Randomized Placebo-Controlled Trial, Dr. Michael Shanahan. Dr. Shanahan’s study, most recently published in “Arthritis & Rheumatology” attempts to determine the efficacy of...